{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:45:17Z","timestamp":1788090317743,"version":"build-2803163510"},"reference-count":37,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Regione Sardegna"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Background: Aripiprazole is an atypical antipsychotic that acts as a partial agonist on the dopamine receptor D2 while also displaying agonistic activity on the 5-HT1A and antagonistic activity on the 5-HT2A receptors. As a partial agonist, aripiprazole stabilizes the activity of the D2 receptor, preventing overactivation. Case presentation: Within our deprescribing activity, we came across the case of a 30-year-old antipsychotic-na\u00efve patient treated with the depot formulation of aripiprazole for bipolar disorder and acute mania, possibly developing hypersexuality due to an overdose that impacted negatively and heavily on his personal life. Results: The patient developed a peculiar subset of hypersexuality, changing his sexual orientation. Of interest, one month after discontinuing aripiprazole and switching to paliperidone, all the sexual-related symptoms and impulse control disorders resolved. Conclusions: We suggest stronger communication among the clinical teams involved in the patient\u2019s care and screening patients for impulse control disorder prior to the administration of aripiprazole and monitoring them during treatment.<\/jats:p>","DOI":"10.3390\/clinpract16010019","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:36:33Z","timestamp":1768898193000},"page":"19","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Hypersexuality Subset Behavior Induced by Aripiprazole Overdose in an Antipsychotic Na\u00efve Patient: A Case Report and Review of the Literature"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5516-1023","authenticated-orcid":false,"given":"Tiziano","family":"Serfilippi","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences and Public Health, School of Medicine, University \u201cPolitecnica delle Marche\u201d, Via Tronto 10\/A, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7608-5589","authenticated-orcid":false,"given":"Silvia","family":"Piccirillo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Public Health, School of Medicine, University \u201cPolitecnica delle Marche\u201d, Via Tronto 10\/A, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Preziuso","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Public Health, School of Medicine, University \u201cPolitecnica delle Marche\u201d, Via Tronto 10\/A, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1392-1023","authenticated-orcid":false,"given":"Valentina","family":"Terenzi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Public Health, School of Medicine, University \u201cPolitecnica delle Marche\u201d, Via Tronto 10\/A, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Romagnoli","sequence":"additional","affiliation":[{"name":"Servizio Territoriale Dipendenze Patologiche, Ospedale di Senigallia, AST-Ancona, Via Cellini 1, 60019 Senigallia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marella","family":"Tarini","sequence":"additional","affiliation":[{"name":"Servizio Territoriale Dipendenze Patologiche, Ospedale di Senigallia, AST-Ancona, Via Cellini 1, 60019 Senigallia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1518-1495","authenticated-orcid":false,"given":"Vincenzo","family":"Lariccia","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Public Health, School of Medicine, University \u201cPolitecnica delle Marche\u201d, Via Tronto 10\/A, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Secondo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Public Health, School of Medicine, University \u201cPolitecnica delle Marche\u201d, Via Tronto 10\/A, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Magi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Public Health, School of Medicine, University \u201cPolitecnica delle Marche\u201d, Via Tronto 10\/A, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1049909115612800","article-title":"Aripiprazole","volume":"34","author":"Prommer","year":"2017","journal-title":"Am. J. Hosp. Palliat. Care."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials","volume":"41","author":"Papanastasiou","year":"2015","journal-title":"Schizophr. Bull."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852915000954","article-title":"Mechanism of action of brexpiprazole: Comparison with aripiprazole","volume":"21","author":"Stahl","year":"2016","journal-title":"CNS Spectr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ddstr.2006.10.014","article-title":"Partial agonism of dopamine, serotonin and opiate receptors for psychiatry","volume":"3","author":"Yocca","year":"2006","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4306\/pi.2013.10.2.200","article-title":"Two cases of hypersexuality probably associated with aripiprazole","volume":"10","author":"Cheon","year":"2013","journal-title":"Psychiatry Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacol"},{"key":"ref_7","unstructured":"(2025, June 30). FDA Drug Safety Communication: FDA Warns About New Impulse-Control Problems Associated with Mental Health Drug Aripiprazole (Abilify, Abilify Maintena, Aristada), Available online: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-new-impulse-control-problems-associated-mental-health."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0149-7634(94)00020-2","article-title":"Dopamine and sexual behavior","volume":"19","author":"Melis","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0165-0173(96)82985-7","article-title":"Regulation of masculine sexual behavior: Involvement of brain opioids and dopamine","volume":"21","author":"Wolterink","year":"1995","journal-title":"Brain Res. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.22505","article-title":"Impulsive and compulsive behaviors in Parkinson\u2019s disease","volume":"24","author":"Evans","year":"2009","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Calabr\u00f2, R.S., Cacciola, A., Bruschetta, D., Milardi, D., Quattrini, F., Sciarrone, F., la Rosa, G., Bramanti, P., and Anastasi, G. (2019). Neuroanatomy and function of human sexual behavior: A neglected or unknown issue?. Brain Behav., 9.","DOI":"10.1002\/brb3.1389"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson\u2019s disease and multiple system atrophy","volume":"11","author":"Klos","year":"2005","journal-title":"Park. Relat. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1503\/jpn.190053","article-title":"Management of sexual adverse effects induced by atypical antipsychotic medication","volume":"44","author":"Downing","year":"2019","journal-title":"J. Psychiatry Neurosci. JPN"},{"key":"ref_15","first-page":"74","article-title":"Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study","volume":"50","author":"Fujioi","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1527-3458.2004.tb00030.x","article-title":"Aripiprazole: A novel atypical antipsychotic drug with a uniquely robust pharmacology","volume":"10","author":"Davies","year":"2004","journal-title":"CNS Drug Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"Lawler","year":"1999","journal-title":"Neuropsychopharmacol"},{"key":"ref_19","first-page":"5557211","article-title":"A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia","volume":"2021","author":"Priya","year":"2021","journal-title":"Case Rep. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pnp.556","article-title":"Hypersexuality and new sexual orientation following aripiprazole use","volume":"24","author":"Mousailidis","year":"2020","journal-title":"Prog. Neurol. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S1461145709990976","article-title":"Aripiprazole-induced behavioural disturbance related to impulse control in a clinical setting","volume":"13","author":"Kodama","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_22","first-page":"26650","article-title":"Aripiprazole-Induced Hypersexuality","volume":"18","author":"Bulbena","year":"2016","journal-title":"Prim. Care Companion CNS Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s40265-015-0474-y","article-title":"Flibanserin: First Global Approval","volume":"75","author":"Deeks","year":"2015","journal-title":"Drugs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/JCP.0b013e31818582de","article-title":"Aripiprazole induced hypersexuality in a 24-year-old female patient with schizoaffective disorder?","volume":"28","author":"Schlachetzki","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_25","unstructured":"Pierrelus, C., Patel, P., and Carlson, K. (2024, July 11). Flibanserin, StatPearls [Internet], Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK589649\/."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00737-016-0693-6","article-title":"Flibanserin and its discontents","volume":"20","author":"Aftab","year":"2017","journal-title":"Arch. Womens Ment. Health"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.brainres.2004.07.070","article-title":"Differential brain activation in exclusively homosexual and heterosexual men produced by the selective serotonin reuptake inhibitor, fluoxetine","volume":"1024","author":"Kinnunen","year":"2004","journal-title":"Brain Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature09822","article-title":"Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice","volume":"472","author":"Liu","year":"2011","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2004.04.028","article-title":"Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain","volume":"493","author":"Li","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2005.06.035","article-title":"Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex","volume":"387","author":"Zocchi","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: A possible mechanism of atypical antipsychotic-induced cortical dopamine release","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J. Neurochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.mp.4001832","article-title":"Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: Desire, arousal and sexual function","volume":"11","author":"Tessler","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pbb.2015.08.012","article-title":"Role of dopamine D4 receptors in copulatory behavior: Studies with selective D4 agonists and antagonists in male rats","volume":"137","author":"Sanna","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Garcia, J.R., MacKillop, J., Aller, E.L., Merriwether, A.M., Wilson, D.S., and Lum, J.K. (2010). Associations between dopamine D4 receptor gene variation with both infidelity and sexual promiscuity. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0014162"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-003-1677-6","article-title":"Aripiprazole (OPC-14597) fully substitutes for the 5-HT1A receptor agonist LY293284 in the drug discrimination assay in rats","volume":"172","author":"Nichols","year":"2004","journal-title":"Psychopharmacology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1523\/JNEUROSCI.5290-07.2008","article-title":"Increased Dopamine Level Enhances Male\u2013Male Courtship in Drosophila","volume":"28","author":"Liu","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S723","DOI":"10.1192\/j.eurpsy.2022.1865","article-title":"Aripiprazol and Hypersexuality: When partial is to much","volume":"65","author":"Mesquita","year":"2022","journal-title":"Eur. Psychiatry"}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/16\/1\/19\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:13:59Z","timestamp":1768900439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/16\/1\/19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["clinpract16010019"],"URL":"https:\/\/doi.org\/10.3390\/clinpract16010019","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]}}}